- Home
- WAT vs EW Comparison
WAT vs EW Comparison
Compare WAT & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WAT | EW |
|---|---|---|
| Founded | 1958 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.2B | 49.1B |
| IPO Year | 1996 | 1999 |
Fundamental Metrics
Financial Performance| Metric | WAT | EW |
|---|---|---|
| Price | $454.33 | $89.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 29 |
| Target Price | ★ $464.30 | $101.81 |
| AVG Volume (30 Days) | 693.2K | ★ 3.2M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.47 | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $103.98 | $11.45 |
| Revenue Next Year | $10.44 | $9.93 |
| P/E Ratio | ★ N/A | $82.48 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $282.77 | $74.66 |
| 52 Week High | $459.18 | $96.29 |
Technical Indicators
Market Signals| Indicator | WAT | EW |
|---|---|---|
| Relative Strength Index (RSI) | 63.63 | 59.29 |
| Support Level | $419.81 | $88.79 |
| Resistance Level | $454.54 | $93.43 |
| Average True Range (ATR) | 14.77 | 2.02 |
| MACD | 1.24 | 0.49 |
| Stochastic Oscillator | 74.79 | 98.15 |
Price Performance
Historical ComparisonAbout WAT Waters Corporation
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.